Asensus Surgical Inc Ordinary Shares ASXC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ASXC is a good fit for your portfolio.
News
-
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
-
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
-
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
-
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
-
Asensus Surgical Shares Rise on FDA Pediatric Nod for Senhance System
Trading Information
- Previous Close Price
- $0.25
- Day Range
- $0.25–0.25
- 52-Week Range
- $0.21–0.69
- Bid/Ask
- $0.25 / $0.25
- Market Cap
- $68.38 Mil
- Volume/Avg
- 735,794 / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.36
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 209
- Website
- https://www.asensus.com
Comparables
Valuation
|
Metric
|
ASXC
|
SSII
|
PRCT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.00 | 65.67 | 9.26 |
Price/Sales | 7.36 | 120.15 | 17.76 |
Price/Cash Flow | — | — | — |
Price/Earnings
ASXC
SSII
PRCT
Financial Strength
|
Metric
|
ASXC
|
SSII
|
PRCT
|
|---|---|---|---|
Quick Ratio | 1.95 | 0.40 | 6.65 |
Current Ratio | 2.88 | 1.98 | 7.63 |
Interest Coverage | — | −39.26 | −27.40 |
Quick Ratio
ASXC
SSII
PRCT
Profitability
|
Metric
|
ASXC
|
SSII
|
PRCT
|
|---|---|---|---|
Return on Assets (Normalized) | −85.67% | −51.18% | −25.31% |
Return on Equity (Normalized) | −112.11% | −130.54% | −38.72% |
Return on Invested Capital (Normalized) | −105.02% | −55.14% | −29.67% |
Return on Assets
ASXC
SSII
PRCT
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gqyxyggm | Xjjks | $185.8 Bil | |
SYK
| Stryker Corp | Hpjwqkmhf | Tdbt | $124.7 Bil | |
MDT
| Medtronic PLC | Zncvrqzm | Tvnxdp | $105.2 Bil | |
BSX
| Boston Scientific Corp | Fxpcblph | Lfnqxs | $99.0 Bil | |
EW
| Edwards Lifesciences Corp | Lxcltvyx | Vhqnrh | $52.3 Bil | |
DXCM
| DexCom Inc | Hdkymxzzn | Jngr | $52.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Slfqrzrb | Hhzz | $24.8 Bil | |
ALGN
| Align Technology Inc | Fjghtlfv | Zjwxhct | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Qgxndmc | Gwsxw | $18.5 Bil | |
PODD
| Insulet Corp | Wvpblhjrq | Cdhvln | $11.5 Bil |